Using a backward stepwise AIC selection model, M2BPGi Category 4 (aHR: 5.60 [95% CI: 2.14–14.62], p < 0.001) remained significant, while Category 3 (aHR: 2.05 [95% CI: 0.39–10.70], p = 0.40), and Category 2 (aHR: 2.54 [95% CI: 0.86–7.53], p = 0.09) showed borderline significance.
← all excerpts
Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.
1
—
—